Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
Clinical trial NCT06545682 · RECRUITING
Trial details
- NCT number
- NCT06545682
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2027-08-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.